

          -  Pregnant or lactating women

          -  Hypersensitivity to tocilizumab

          -  Patients or authorized family member unwilling to sign informed consent to participate
             in this study

          -  Uncontrolled tuberculosis, or any uncontrolled fungal infection (eg: candidemia)
      